An Alternative to the Hype of the HIMSS16 Show Floor

Dave Garets, Healthcare IT industry analyst I know what you’re thinking: “Garets is mouthing off again. Thank goodness he doesn’t do it more than once a year.” Last year about this time I blogged about what you’d see at HIMSS15. Now I’m going to suggest something you ought to check out at HIMSS16 beyond the blather about BI/analytics/big data, population … Read More

Professor spearheads pharmacogenomics learning program for pharmacists

Professor David Kisor saw a need for more pharmacogenomic education for pharmacists, and he wanted to fill it. Dr. Kisor, PharmD, serves as professor and chair of pharmaceutical sciences at Manchester University’s Pharmacy Program, in Fort Wayne, Ind. He’s long been interested in the field of pharmacogenomics, or how individual genetic differences affect drug response, and has written extensively on … Read More

Genelex associate lab director follows life-long passion for pharmacogenetics research

As a 12 year-old-boy in India, Ranjit Thirumaran, M.Pharm, PhD, saw the toll adverse drug reactions can take firsthand. Following hospitalization after a minor accident, his uncle suddenly died, likely due to an adverse drug reaction from a recently administered dose of warfarin. “I was always curious: Could something have been done to save him?” said Dr. Thirumaran, Genelex’s associate … Read More

Gauging the IMPACT of pharmacogenetic testing

Update: The results of this research are in! Find out more here. How can pharmacogenetic testing improve care for elderly patients taking multiple medications? Genelex is trying to find out. As a pioneer in the field of personalized medicine, Genelex, the creators of the YouScript Personalized Prescribing System, is continually investigating ways to further research on the benefits of pharmacogenetic … Read More

NIH panel: Patient-centered approach needed for pain management

Those suffering from chronic pain need individualized care strategies to be best served by their physicians, according to the recent findings of an expert panel convened by the National Institutes of Health (NIH). “Persons living with chronic pain have often been grouped into a single category, and treatment approaches have been generalized with little evidence to support this practice,” said … Read More

2014 concludes with multiple accolades for Genelex

The year 2014 ended on a positive note for Genelex, with multiple publications bestowing the company with six awards or accolades for business growth and technological advancement. In November, Inc. magazine included the Seattle-based company at the number 10 spot in its list of the top-10 fastest-growing private companies in Seattle. Genelex was the only healthcare software and genetic testing company included … Read More

The Future: Pharmacogenetics in Primary Care

Primary care physicians are in a prime position to advance the continued implementation of pharmacogenetic testing to improve patient care, according to a review article in the journal Primary Care Reports. The article, which appeared in the October issue of Primary Care Reports, makes the case that primary care physicians are ideally positioned to advise patients in a manner that … Read More

All that wheezes is not asthma: Doctor uses YouScript to solve puzzling patient case

As cardiopulmonologist Mark Pamer, DO, goes about his day at his South Florida practice, one adage from medical school that sticks in his mind is: “All that wheezes is not asthma.” “[As doctors], we probably all heard that. Did we understand it? You know, probably not,” said Dr. Pamer. “We understood it later on in residency or fellowship or in life.” This adage proved itself during Dr. Pamer’s treatment of a puzzling … Read More

Study: Pharmacogenomic knowledge gaps persist among physicians

More work seems needed to better familiarize physicians with the concept of pharmacogenomic testing, according to the results of a recent study. The study in the August edition of Pharmacogenomics and Personalized Medicine found that just 12.6 percent of the 300 physicians surveyed strongly or somewhat agreed with the question, “How familiar are you with pharmacogenomics?” Study authors Johansen Taber and Dickinson report this study gels with past research on … Read More